Patricia Andres

Title: The Innovative Contributions of Patricia Andres

Introduction

Patricia Andres, based in West Lafayette, IN, is a prolific inventor with a remarkable portfolio of 40 patents. Her work primarily focuses on pharmaceutical innovations, particularly in the development of specialized compounds used in various therapeutic applications.

Latest Patents

Among her most recent patents is the invention involving a crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine, presented as a Syk inhibitor. This patent details the solid forms of the compound and provides comprehensive processes for creating these solid forms and methods of use. Additionally, she has contributed to the purification methods of L-glufosinate, describing solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium.

Career Highlights

Patricia has worked with several innovative companies, including Dermira, Inc. and Ferrokin Biosciences, Inc., where she focused on advancing pharmaceutical technologies. Her contributions have been vital in the development of therapeutic agents aimed at addressing significant health challenges.

Collaborations

Throughout her career, Patricia has collaborated with talented professionals, including her notable coworkers, Lisa Lynn McQueen and Jennifer Leigh Nelson. These collaborations emphasize her commitment to teamwork in driving innovation within the pharmaceutical sector.

Conclusion

Patricia Andres's impactful work in developing patented technologies illustrates her vital role in the field of pharmaceuticals. Her ongoing contributions continue to inspire new advancements that may lead to significant therapeutic breakthroughs for various medical conditions. Her dedication to innovation and collaboration sets a strong example for future inventors in the industry.